NCT00036374View on ClinicalTrials.gov

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

December 31, 2006

Conditions
Rheumatoid Arthritis, Juvenile
Interventions
DRUG

Infliximab

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY